AGIO vs EIX · rev $36.5M vs P/E 7.3, rev $17.60B
Agios Pharm (AGIO) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported AGIO revenue for 2024-12-31 was $36.5M. Net income was $673.7M. Revenue was up 36.1% from 2023-12-31 to 2024-12-31. AGIO currently screens at market cap $1.68B.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
AGIO currently screens at market cap $1.68B. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the AGIO and EIX stock pages for the full models.
Not investment advice.